Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Targeted Genetics cancer gene therapy product approved for European clinical trials

July 28, 1997

Allos Therapeutics reports clinical results of RSR13

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

Sparta's oral chemotherapeutic agent enters clinical trials

July 25, 1997

Cambridge NeuroScience awarded SBIR grant for cancer research

July 25, 1997

Asta prepares and evaluates targeted cytotoxic anthracycline analogues

July 24, 1997

Ansan announces merger with Discovery Laboratories and licensing agreement with Titan

July 24, 1997

IDEC acquires anticancer agent from Pharmacia & Upjohn

July 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.